Legal & General Group’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.7K Buy
3,687
+156
+4% +$1.29K ﹤0.01% 2919
2025
Q4
$36.8K Sell
3,531
-198
-5% -$1.99K ﹤0.01% 2809
2025
Q3
$33.5K Sell
3,729
-40,845
-92% -$358K ﹤0.01% 2836
2025
Q2
$579K Buy
44,574
+2,121
+5% +$31.9K ﹤0.01% 2402
2025
Q1
$1.07M Buy
42,453
+8
+0% +$238 ﹤0.01% 2163
2024
Q4
$1.46M Buy
42,445
+3,947
+10% +$178K ﹤0.01% 2113
2024
Q3
$1.9M Buy
38,498
+4,479
+13% +$229K ﹤0.01% 1992
2024
Q2
$2.05M Buy
34,019
+2,264
+7% +$129K ﹤0.01% 1941
2024
Q1
$1.64M Buy
31,755
+10,209
+47% +$501K ﹤0.01% 2014
2023
Q4
$869K Buy
21,546
+3,666
+21% +$108K ﹤0.01% 2252
2023
Q3
$499K Sell
17,880
-200
-1% -$5.96K ﹤0.01% 2438
2023
Q2
$521K Buy
18,080
+15,240
+537% +$339K ﹤0.01% 2451
2023
Q1
$47.4K Buy
2,840
+314
+12% +$4.43K ﹤0.01% 2887
2022
Q4
$32K Hold
2,526
﹤0.01% 3038
2022
Q3
$30K Buy
2,526
+313
+14% +$4.3K ﹤0.01% 3102
2022
Q2
$31K Buy
2,213
+440
+25% +$5.8K ﹤0.01% 3106
2022
Q1
$22K Buy
1,773
+947
+115% +$11.4K ﹤0.01% 3218
2021
Q4
$9K Hold
826
﹤0.01% 3477
2021
Q3
$10K Buy
+826
New +$11.4K ﹤0.01% 3447

Other funds holding RXST

Legal & General Group's RXST Position: Q1 2026 in Review

Legal & General Group increased its RxSight (RXST) stake by 4.4% in Q1 2026, buying an estimated $1.29K and bringing the position to 3,687 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2919.

Legal & General Group first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.05M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Legal & General Group held 3,687 shares of RxSight worth $22.7K as of Q1 2026.
  • Legal & General Group bought 156 RxSight shares in Q1 2026, an estimated $1.29K.
  • RxSight made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2919 holding.
  • Legal & General Group first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
  • Legal & General Group's RxSight position peaked at $2.05M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.